Cargando…
The Evolution of the Safety of Plasma Products from Pathogen Transmission—A Continuing Narrative
Chronic recipients of plasma products are at risk of infection from blood-borne pathogens as a result of their inevitable exposure to agents which will contaminate a plasma manufacturing pool made up of thousands of individual donations. The generation of such a pool is an essential part of the larg...
Autor principal: | Farrugia, Albert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967166/ https://www.ncbi.nlm.nih.gov/pubmed/36839590 http://dx.doi.org/10.3390/pathogens12020318 |
Ejemplares similares
-
Current concepts in the prevention of pathogen transmission via blood/plasma-derived products for bleeding disorders()
por: Di Minno, Giovanni, et al.
Publicado: (2016) -
Manufacture of Immunoglobulin Products for Patients with Primary Antibody Deficiencies – The Effect of Processing Conditions on Product Safety and Efficacy
por: Farrugia, Albert, et al.
Publicado: (2014) -
In vivo continuous evolution of metabolic pathways for chemical production
por: Tan, Zheng Lin, et al.
Publicado: (2019) -
Plasma procurement and plasma product safety in light of the COVID‐19 pandemic from the perspective of the plasma industry
por: Turecek, Peter L., et al.
Publicado: (2022) -
Antigenic Diversity, Transmission Mechanisms, and the Evolution of Pathogens
por: Lange, Alexander, et al.
Publicado: (2009)